Global Skin Biopsy Market Overview:
Global Skin Biopsy Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2026-2035, Considering the Base Year As 2025.
Global Skin Biopsy Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Skin Biopsy involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Skin Biopsy Market:
The Skin Biopsy Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Skin Biopsy Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Skin Biopsy Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Skin Biopsy market has been segmented into:
Excisional Biopsy
Incisional Biopsy
Shave Biopsy
Punch Biopsy
By Application, Skin Biopsy market has been segmented into:
Surgical Biopsy
Needle Biopsy
Liquid Biopsy
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Skin Biopsy market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Skin Biopsy market.
Top Key Players Covered in Skin Biopsy market are:
Thermo Fisher Scientific
Horizon Therapeutics
Boehringer Ingelheim
Miltenyi Biotec
Abbott Laboratories
Amgen
Dako
HoffmannLa Roche
Pfizer
DermTech
Epic Sciences
MediWound
Merck and Co
AstraZeneca
Sakura Finetech
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Skin Biopsy Market Type
4.1 Skin Biopsy Market Snapshot and Growth Engine
4.2 Skin Biopsy Market Overview
4.3 Excisional Biopsy
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Excisional Biopsy: Geographic Segmentation Analysis
4.4 Incisional Biopsy
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.4.3 Incisional Biopsy: Geographic Segmentation Analysis
4.5 Shave Biopsy
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.5.3 Shave Biopsy: Geographic Segmentation Analysis
4.6 Punch Biopsy
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.6.3 Punch Biopsy: Geographic Segmentation Analysis
Chapter 5: Skin Biopsy Market Application
5.1 Skin Biopsy Market Snapshot and Growth Engine
5.2 Skin Biopsy Market Overview
5.3 Surgical Biopsy
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Surgical Biopsy: Geographic Segmentation Analysis
5.4 Needle Biopsy
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.4.3 Needle Biopsy: Geographic Segmentation Analysis
5.5 Liquid Biopsy
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.5.3 Liquid Biopsy: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Skin Biopsy Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 THERMO FISHER SCIENTIFIC
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 HORIZON THERAPEUTICS
6.4 BOEHRINGER INGELHEIM
6.5 MILTENYI BIOTEC
6.6 ABBOTT LABORATORIES
6.7 AMGEN
6.8 DAKO
6.9 HOFFMANNLA ROCHE
6.10 PFIZER
6.11 DERMTECH
6.12 EPIC SCIENCES
6.13 MEDIWOUND
6.14 MERCK AND CO
6.15 ASTRAZENECA
6.16 SAKURA FINETECH
Chapter 7: Global Skin Biopsy Market By Region
7.1 Overview
7.2. North America Skin Biopsy Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Excisional Biopsy
7.2.2.2 Incisional Biopsy
7.2.2.3 Shave Biopsy
7.2.2.4 Punch Biopsy
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Surgical Biopsy
7.2.3.2 Needle Biopsy
7.2.3.3 Liquid Biopsy
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Skin Biopsy Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Excisional Biopsy
7.3.2.2 Incisional Biopsy
7.3.2.3 Shave Biopsy
7.3.2.4 Punch Biopsy
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Surgical Biopsy
7.3.3.2 Needle Biopsy
7.3.3.3 Liquid Biopsy
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Skin Biopsy Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Excisional Biopsy
7.4.2.2 Incisional Biopsy
7.4.2.3 Shave Biopsy
7.4.2.4 Punch Biopsy
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Surgical Biopsy
7.4.3.2 Needle Biopsy
7.4.3.3 Liquid Biopsy
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Skin Biopsy Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Excisional Biopsy
7.5.2.2 Incisional Biopsy
7.5.2.3 Shave Biopsy
7.5.2.4 Punch Biopsy
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Surgical Biopsy
7.5.3.2 Needle Biopsy
7.5.3.3 Liquid Biopsy
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Skin Biopsy Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Excisional Biopsy
7.6.2.2 Incisional Biopsy
7.6.2.3 Shave Biopsy
7.6.2.4 Punch Biopsy
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Surgical Biopsy
7.6.3.2 Needle Biopsy
7.6.3.3 Liquid Biopsy
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Skin Biopsy Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Excisional Biopsy
7.7.2.2 Incisional Biopsy
7.7.2.3 Shave Biopsy
7.7.2.4 Punch Biopsy
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Surgical Biopsy
7.7.3.2 Needle Biopsy
7.7.3.3 Liquid Biopsy
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Skin Biopsy Scope:
|
Report Data
|
Skin Biopsy Market
|
|
Skin Biopsy Market Size in 2025
|
USD XX million
|
|
Skin Biopsy CAGR 2025 - 2032
|
XX%
|
|
Skin Biopsy Base Year
|
2024
|
|
Skin Biopsy Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Thermo Fisher Scientific, Horizon Therapeutics, Boehringer Ingelheim, Miltenyi Biotec, Abbott Laboratories, Amgen, Dako, HoffmannLa Roche, Pfizer, DermTech, Epic Sciences, MediWound, Merck and Co, AstraZeneca, Sakura Finetech.
|
|
Key Segments
|
By Type
Excisional Biopsy
Incisional Biopsy
Shave Biopsy
Punch Biopsy
By Applications
Surgical Biopsy
Needle Biopsy
Liquid Biopsy
|
